Cardiovascular disease and the impact of COVID-19.

Yoganathan, Anusha; Sajjad, Menahel S; Harky, Amer

Yoganathan, Anusha; Sajjad, Menahel S; Harky, Amer.

Yoganathan A; University of Liverpool, Liverpool, UK.
Sajjad MS; University of Liverpool, Liverpool, UK.
Harky A; University of Liverpool, Liverpool, UK.

J Card Surg ; 35(8): 2113, 2020 Aug.

Article in English | MEDLINE | ID: covidwho-599321

Subject(s)

Angiotensin Receptor Antagonists/therapeutic use; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Betacoronavirus/pathogenicity; Coronavirus Infections/epidemiology; Peptidyl-Dipeptidase A/physiology; Pneumonia, Viral/epidemiology; Virus Attachment; Angiotensin-Converting Enzyme 2; COVID-19; Cardiovascular Diseases/epidemiology; Humans; Pandemics; Renin-Angiotensin System/physiology; Risk Assessment; SARS-CoV-2

Keywords

COVID-19; cardiovascular; heart

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Peptidyl-Dipeptidase A / Virus Attachment / Angiotensin Receptor Antagonists / Betacoronavirus Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: J Card Surg Journal subject: Cardiology Year: 2020 Document Type: Article Affiliation country: Jocs.14682

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google